Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fluorinex Ltd. was an innovative medical technology company based in Israel that developed a proprietary system for advanced dental care and caries prevention. The company's flagship product, the Fluorinex System, utilized an electrochemical process known as electrophoresis to significantly enhance the uptake of fluoride into tooth enamel. By replacing hydroxyl ions with fluoride ions in a matter of minutes, the system converted hydroxyapatite into more acid-resistant fluorapatite, providing superior protection against cavities compared to traditional topical treatments. The technology was also applied to the treatment of dentin hypersensitivity, offering a rapid and long-lasting solution for patients by effectively sealing exposed tubules. Although the company achieved regulatory clearances and initiated commercialization in several global markets, it eventually ceased operations and is currently considered inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fluorinex.